Stocks
Daiichi Sankyo Company, LimitedDSKYF
OTCHealthcarePharmaceuticals$17.53-2.61%
A Japan-based pharmaceutical manufacturer focused on oncology, cardiovascular, and specialty medicines, with a growing emphasis on antibody-drug conjugate cancer therapies. The company has drawn investor attention through global partnerships, including a major collaboration with AstraZeneca to comme...
Market Cap: $32.4B52W Range: $16.81 – $29.15
Congressional Interest in Daiichi Sankyo Company, Limited (DSKYF)
3 members of Congress have disclosed 3 trades in Daiichi Sankyo Company, Limited (DSKYF), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
3
Buys
1
Sells
2
Who in Congress Is Trading DSKYF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-03 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-04-04 | David P. Roe | buy | $1K – $15K |